2.86
price down icon11.46%   -0.37
pre-market  Vorhandelsmarkt:  2.79   -0.07   -2.45%
loading
Schlusskurs vom Vortag:
$3.23
Offen:
$3.03
24-Stunden-Volumen:
32,504
Relative Volume:
0.14
Marktkapitalisierung:
$3.78M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-38.35M
KGV:
-1.9724
EPS:
-1.45
Netto-Cashflow:
$-36.91M
1W Leistung:
-16.62%
1M Leistung:
-28.68%
6M Leistung:
-75.84%
1J Leistung:
-84.38%
1-Tages-Spanne:
Value
$2.75
$3.13
1-Wochen-Bereich:
Value
$2.75
$3.53
52-Wochen-Spanne:
Value
$2.75
$19.75

Galecto Inc Stock (GLTO) Company Profile

Name
Firmenname
Galecto Inc
Name
Telefon
45-70-70-52-10
Name
Adresse
75 STATE STREET, BOSTON
Name
Mitarbeiter
5
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
GLTO's Discussions on Twitter

Vergleichen Sie GLTO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GLTO
Galecto Inc
2.86 3.78M 0 -38.35M -36.91M -1.45
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 66.76B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

Galecto Inc Stock (GLTO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-04-26 Fortgesetzt Credit Suisse Outperform
2020-11-23 Eingeleitet BofA Securities Buy
2020-11-23 Eingeleitet Credit Suisse Outperform
2020-11-23 Eingeleitet SVB Leerink Outperform

Galecto Inc Aktie (GLTO) Neueste Nachrichten

pulisher
Apr 03, 2025

Galecto, Inc. Focuses on Oncology and Liver Diseases - TipRanks

Apr 03, 2025
pulisher
Mar 27, 2025

Galecto stock hits 52-week low at $3.75 amid market challenges - Investing.com

Mar 27, 2025
pulisher
Mar 27, 2025

Galecto stock hits 52-week low at $3.75 amid market challenges By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 26, 2025

Galecto stock hits 52-week low at $4.39 amid market challenges - MSN

Mar 26, 2025
pulisher
Mar 25, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Mar 25, 2025
pulisher
Mar 25, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Mar 25, 2025
pulisher
Mar 21, 2025

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Mar 21, 2025
pulisher
Mar 21, 2025

Galecto (GLTO) Shares Rally Amid Positive Market Momentum - Stocks Telegraph

Mar 21, 2025
pulisher
Mar 19, 2025

Galecto Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 19, 2025
pulisher
Mar 19, 2025

Galecto Reports Full-Year 2024 Financial Results - The Manila Times

Mar 19, 2025
pulisher
Mar 19, 2025

Galecto Cuts Losses by $17M, Acquires Promising AML Drug Candidate - StockTitan

Mar 19, 2025
pulisher
Mar 19, 2025

Galecto Inc expected to post a loss of $2.97 a shareEarnings Preview - TradingView

Mar 19, 2025
pulisher
Mar 14, 2025

Idiopathic Pulmonary Fibrosis Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, IND, NDA Approvals, Therapies, Mechanism of Action, Route of Administration & Companies by DelveInsight - The Globe and Mail

Mar 14, 2025
pulisher
Mar 12, 2025

Galecto stock plunges to 52-week low at $3.76 amid market challenges - Investing.com Australia

Mar 12, 2025
pulisher
Mar 07, 2025

Galecto (GLTO) Projected to Post Quarterly Earnings on Friday - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Mustang Bio Stock Price, Quotes and Forecasts | NASDAQ:MBIO - Benzinga

Mar 06, 2025
pulisher
Feb 28, 2025

Ensysce Biosciences Stock Price, Quotes and Forecasts | NASDAQ:ENSC - Benzinga

Feb 28, 2025
pulisher
Feb 28, 2025

Galecto stock hits 52-week low at $4.20 amid market challenges - Investing.com Australia

Feb 28, 2025
pulisher
Feb 27, 2025

Galecto stock hits 52-week low at $4.20 amid market challenges By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 15, 2025

Eterna Therapeutics (NASDAQ:ERNA) & Galecto (NASDAQ:GLTO) Head to Head Comparison - Defense World

Feb 15, 2025
pulisher
Feb 12, 2025

Reviewing Eton Pharmaceuticals (NASDAQ:ETON) & Galecto (NASDAQ:GLTO) - Defense World

Feb 12, 2025
pulisher
Feb 11, 2025

Galecto to Participate in Upcoming Investor Conferences - The Globe and Mail

Feb 11, 2025
pulisher
Feb 11, 2025

Galecto stock hits 52-week low at $4.39 amid market challenges By Investing.com - Investing.com South Africa

Feb 11, 2025
pulisher
Feb 11, 2025

Leerink Partnrs Estimates Galecto FY2024 Earnings - Defense World

Feb 11, 2025
pulisher
Feb 08, 2025

Brokers Set Expectations for Galecto FY2029 Earnings - Armenian Reporter

Feb 08, 2025
pulisher
Feb 06, 2025

Galecto to Participate in Upcoming Investor Conferences -February 06, 2025 at 08:01 am EST - Marketscreener.com

Feb 06, 2025
pulisher
Feb 06, 2025

Biotech Spotlight: Galecto Lines Up Triple Conference Showcase for Investors - StockTitan

Feb 06, 2025
pulisher
Feb 01, 2025

Where are the Opportunities in (GLTO) - Stock Traders Daily

Feb 01, 2025
pulisher
Jan 24, 2025

Sunshine Biopharma (NASDAQ:SBFM) Stock Quotes, Forecast and News Summary - Benzinga

Jan 24, 2025
pulisher
Jan 23, 2025

Critical Analysis: Galecto (NASDAQ:GLTO) vs. ObsEva (NASDAQ:OBSV) - Defense World

Jan 23, 2025
pulisher
Jan 22, 2025

(GLTO) On The My Stocks Page - Stock Traders Daily

Jan 22, 2025
pulisher
Jan 13, 2025

Analyzing Galecto (NASDAQ:GLTO) and Pasithea Therapeutics (NASDAQ:KTTA) - Defense World

Jan 13, 2025
pulisher
Jan 09, 2025

After layoffs, a viral immunotherapy biotech bounced back with a late-stage prostate cancer win - PharmaVoice

Jan 09, 2025
pulisher
Jan 07, 2025

Galecto CEO Hans T. Schambye sells $7,509 in shares - Investing.com

Jan 07, 2025
pulisher
Jan 03, 2025

Galecto (NASDAQ:GLTO) Shares Up 22.6% – Should You Buy? - Defense World

Jan 03, 2025
pulisher
Jan 01, 2025

When (GLTO) Moves Investors should Listen - Stock Traders Daily

Jan 01, 2025
pulisher
Dec 18, 2024

Galecto stock plunges to 52-week low at $4.78 amid market challenges - Investing.com Australia

Dec 18, 2024
pulisher
Dec 12, 2024

Galecto stock hits 52-week low at $5.26 amid market challenges - Investing.com Nigeria

Dec 12, 2024
pulisher
Dec 12, 2024

Galecto stock hits 52-week low at $5.26 amid market challenges By Investing.com - Investing.com South Africa

Dec 12, 2024

Finanzdaten der Galecto Inc-Aktie (GLTO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Kapitalisierung:     |  Volumen (24h):